Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: A likely constituent biomarker for recurrence

American Journal of Pathology

Volumn 175, Issue 2, 2009, Pages 479-488

  Shen, Fanghua ^a   Liu, Xishi ^a   Geng, Jian Guo ^b,c   Guo, Sun Wei ^d  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RETINOBLASTOMA PROTEIN; ROUNDABOUT RECEPTOR; SLIT PROTEIN;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROVASCULATURE; OVARIAN ENDOMETRIOMA; OVARY TUMOR; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; SENSITIVITY AND SPECIFICITY;

EID: 68449087192     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090024     Document Type: Article

References (50)

1. Farquhar CM: Extracts from the "clinical evidence." Endometriosis, BMJ 2000, 320:1449-1452
2. Garry R: The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol 2004, 16:299-303
3. Evers JL, Dunselman GA, Land JA, Bouckaert PX: Management of Recurrent Endometriosis. Edited by Couinho E, Spinola P, DeMoura LH. London, Partheon, 1995, pp. 291-297
4. Ragni G, Somigliana E, Benedetti F, Paffoni A, Vegetti W, Restelli L, Crosignani PG: Damage to ovarian reserve associated with laparoscopic excision of endometriomas: a quantitative rather than a qualitative injury. Am J Obstet Gynecol 2005, 193:1908-1914
5. Hachisuga T, Kawarabayashi T: Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod 2002, 17:432-435
6. Somigliana E, Ragni G, Benedetti F, Borroni R, Vegetti W, Crosignani PG: Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod 2003, 18:2450-2453
7. Somigliana E, Ragni G, Infantino M, Benedetti F, Arnoldi M, Crosignani PG: Does laparoscopic removal of nonendometriotic benign ovarian cysts affect ovarian reserve? Acta Obstet Gynecol Scand 2006, 85:74-77
8. Candiani M, Barbieri M, Bottani B, Bertulessi C, Vignali M, Agnoli B, Somigliana E, Busacca M: Ovarian recovery after laparoscopic enucleation of ovarian cysts: insights from echographic short-term post-surgical follow-up. J Minim Invasive Gynecol 2005, 12:409-414
9. Nisolle-Pochet M, Casanas-Roux F, Donnez J: Histologic study of ovarian endometriosis after hormonal therapy. Fertil Steril 1988, 49:423-426
10. Vignali M, Bianchi S, Candiani M, Spadaccini G, Oggioni G, Busacca M: Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol 2005, 12:508-513
11. Exacoustos C, Zupi E, Amadio A, Amoroso C, Szabolcs B, Romanini ME, Arduini D: Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow-up and indication for second surgery. J Minim Invasive Gynecol 2006, 13:281-288
12. Bulletti C, DeZiegler D, Stefanetti M, Cicinelli E, Pelosi E, Flamigni C: Endometriosis: absence of recurrence in patients after endometrial ablation. Hum Reprod 2001, 16:2676-2679
13. Noel JC, Chapron C, Fayt I, Anaf V: Lymph node involvement and lymphovascular invasion in deep infiltrating rectosigmoid endometriosis. Fertil Steril 2008, 89:1069-1072
14. Insabato L, Pettinato G: Endometriosis of the bowel with lymph node involvement. A report of three cases and review of the literature. Pathol Res Pract 1996, 192:957-961; discussion 962
15. Lorente Poyatos R, Palacios Perez A, Bravo Bravo F, Lopez Caballero FJ, Bouhmidi A, Huertas Nadal C, Ruiz Escolano E: [Rectosigmoid endometriosis with lymph node involvement]. Gastroenterol Hepatol 2003, 26:23-25
16. Sheikh HA, Krishnamurti U, Bhat Y, Rajendiran S: A 42-year-old woman with a 7-month history of abdominal pain. A, endometriosis involving ileocecal junction and 2 pericolonic lymph nodes; B, intranodal benign glandular inclusions. Arch Pathol Lab Med 2005, 129:e218-e221
17. Thomakos N, Rodolakis A, Vlachos G, Papaspirou I, Markaki S, Antsaklis A: A rare case of rectovaginal endometriosis with lymph node involvement. Gynecol Obstet Invest 2006, 62:45-47
18. Groothuis PG, Nap AW, Winterhager E, Grummer R: Vascular development in endometriosis. Angiogenesis 2005, 8:147-156
19. Taylor RN, Yu J, Torres PB, Schickedanz AC, Park JK, Mueller MD, Sidell N: Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 2009, 16:140-146
20. Becker CM, D'Amato RJ: Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res 2007, 74:121-130
21. McLaren J, Prentice A, Charnock-Jones DS, Smith SK: Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996, 11:220-223
22. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M: Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998, 13:1686-1690
23. Deguchi M, Ishiko O, Sumi T, Yoshida H, Yamamoto K, Ogita S: Expression of angiogenic factors in extrapelvic endometriosis. Oncol Rep 2001, 8:1317-1319
24. Taylor RN, Lebovic DI, Mueller MD: Angiogenic factors in endometriosis. Ann NY Acad Sci 2002, 955:89-100; discussion 118, 396-406
25. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD, Fan TP, Smith SK: Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 2003, 88:2889-2899
26. Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL, Groothuis PG: Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004, 89:1089-1095
27. Laschke MW, Schwender C, Scheuer C, Vollmar B, Menger MD: Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod 2008, 23:2308-2318
28. Laschke MW, Elitzsch A, Vollmar B, Vajkoczy P, Menger MD: Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 2006, 21:262-268
29. Brose K, Bland KS, Wang KH, Arnott D, Henzel W, Goodman CS, Tessier-Lavigne M, Kidd T: Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 1999, 96:795-806
30. Wang KH, Brose K, Arnott D, Kidd T, Goodman CS, Henzel W, Tessier-Lavigne M: Biochemical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching. Cell 1999, 96:771-784
31. Wu W, Wong K, Chen J, Jiang Z, Dupuis S, Wu JY, Rao Y: Directional guidance of neuronal migration in the olfactory system by the protein Slit. Nature 1999, 400:331-336
32. Wu JY, Feng L, Park HT, Havlioglu N, Wen L, Tang H, Bacon KB, Jiang Z, Zhang X, Rao Y: The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001, 410:948-952
33. Huminiecki L, Gorn M, Suchting S, Poulsom R, Bicknell R: Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics 2002, 79:547-552
34. Wang B, Xiao Y, Ding BB, Zhang N, Yuan X, Gui L, Qian KX, Duan S, Chen Z, Rao Y, Geng JG: Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 2003, 4:19-29
35. Bedell VM, Yeo SY, Park KW, Chung J, Seth P, Shivalingappa V, Zhao J, Obara T, Sukhatme VP, Drummond IA, Li DY, Ramchandran R: Roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci USA 2005, 102:6373-6378
36. Gronroos M, Salmi TA, Vuento MH, Jalava EA, Tyrkko JE, Maatela JI, Aromaa AR, Siegberg R, Savolainen ER, Kauraniemi TV: Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension. Cancer 1993, 71:1279-1282
37. Wang LJ, Zhao Y, Han B, Ma YG, Zhang J, Yang DM, Mao JW, Tang FT, Li WD, Yang Y, Wang R, Geng JG: Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. Cancer Sci 2008, 99:510-517
38. Mai KT, Teo I, Al Moghrabi H, Marginean EC, Veinot JP: Calretinin and CD34 immunoreactivity of the endometrial stroma in normal endometrium and change of the immunoreactivity in dysfunctional uterine bleeding with evidence of 'disordered endometrial stroma'. Pathology 2008, 40:493-499
39. Shen F, Wang Y, Lu Y, Yuan L, Liu X, Guo SW: Immunoreactivity of progesterone receptor isoform B and nuclear factor kappa-B as biomarkers for recurrence of ovarian endometriomas. Am J Obstet Gynecol 2008, 199:486.e1-e10
40. Yuan L, Shen F, Lu Y, Liu X, Guo SW: Cyclooxygenase-2 overexpression in ovarian endometriomas is associated with higher risk of recurrence. Fertil Steril 2009, 91:1303-1306
41. Exacoustos C, Zupi E, Carusotti C, Rinaldo D, Marconi D, Lanzi G, Arduini D: Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc 2003, 10:378-382
42. Liu X, Yuan L, Shen F, Zhu Z, Jiang H, Guo SW: Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol 2007, 109:1411-1420
43. Tukey JW: Exploratory Data Analysis. Reading MA, Addison-Wesley, 1977, p. 27
44. Inhaka R, Gentleman RR: R: a language for data analysis and graphics. J comput Graph Statist 1996, 5:1923-1927
45. Robb AO, Mills NL, Smith IB, Short A, Tura-Ceide O, Barclay GR, Blomberg A, Critchley HO, Newby DE, Denison FC: Influence of menstrual cycle on circulating endothelial progenitor cells. Hum Reprod 2009, 24:619-625
46. Girling JE, Rogers PA: Recent advances in endometrial angiogenesis research. Angiogenesis 2005, 8:89-99
47. Carmeliet P: Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 2003, 4:710-720
48. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD: Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst 2008, 100:1432-1438
49. Ransohoff DF: Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 2005, 5:142-149
50. Morlot C, Thielens NM, Ravelli RB, Hemrika W, Romijn RA, Gros P, Cusack S, McCarthy AA: Structural insights into the Slit-Robo complex. Proc Natl Acad Sci USA 2007, 104:14923-14928